시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
백혈구 성분채집술 시장 규모, 점유율, 성장 분석, 유형별, 용도별, 최종 사용자별, 지역별 - 산업별 예측(2024-2031년)
Leukapheresis Market Size, Share, Growth Analysis, By Type (Disposables, Devices), By Application (Research Applications, Therapeutic Applications), By End User, By Region - Industry Forecast 2024-2031
상품코드 : 1619268
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 157 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,665,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,967,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,268,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

백혈구 성분채집술 세계 시장 규모는 2022년 6,630만 달러로 평가되었고, 2023년 7,187만 달러에서 2031년에는 1억 3,702만 달러로 성장할 것으로 예상되며, 예측 기간(2024-2031년) 동안 8.40%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

세계의 백혈구 성분채집술 시장은 혈액 질환 및 자가 면역 질환 증가로 인해 크게 성장하고 있습니다. 백혈구를 선택적으로 분리하는 이 과정은 진단 방법을 발전시키는 동시에 백혈병 및 자가면역질환과 같은 질환의 치료에 중요한 역할을 하고 있습니다. 백혈구 제거 치료 시스템의 기술 혁신은 시술의 효과와 안전성을 향상시켜 신뢰할 수 있는 치료 옵션으로서의 매력을 높이고 있습니다. 그러나 필요한 장비와 숙련된 인력에 대한 인식 부족과 높은 비용으로 인해 시장 성장에 걸림돌이 될 수 있습니다. 특히 백혈구 성분채집술과 개인 맞춤형 의료, CAR-T 세포 치료와 같은 세포 기반 치료가 교차하는 분야는 치료 기회가 풍부합니다. 헬스케어 인프라가 발전함에 따라 연구와 비용 효율적인 솔루션에 대한 투자로 이 중요한 시장 분야는 더욱 확대될 수 있습니다.

목차

서론

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

백혈구 성분채집술 시장 규모 : 유형별

백혈구 성분채집술 시장 규모 : 용도별

백혈구 성분채집술 시장 규모 : 최종사용자별

백혈구 성분채집술 시장 규모 : 지역별

경쟁 정보

주요 기업 개요

결론과 추천 사항

LSH
영문 목차

영문목차

Global Leukapheresis Market size was valued at USD 66.3 million in 2022 and is poised to grow from USD 71.87 million in 2023 to USD 137.02 million by 2031, growing at a CAGR of 8.40% during the forecast period (2024-2031).

The global leukapheresis market is experiencing significant growth, driven by rising incidences of hematologic disorders and autoimmune diseases. This process of selectively separating white blood cells plays a crucial role in treating conditions like leukemia and autoimmune disorders while advancing diagnostic methods. Technological innovations in leukapheresis systems have improved procedure efficacy and safety, enhancing their appeal as a reliable therapeutic option. However, market growth could be hindered by limited awareness and high costs associated with the necessary equipment and trained personnel. Opportunities abound, especially in the intersection of leukapheresis and personalized medicine, as well as cell-based therapies like CAR T-cell treatment. As healthcare infrastructure develops, investment in research and cost-effective solutions could further expand this vital market sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Leukapheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Leukapheresis Market Segmental Analysis

Global Leukapheresis Market is segmented by Type, Application, End User, and region. Based on Type, the market is segmented into Disposables, Devices. Based on Application, the market is segmented into Research Applications, Therapeutic Applications. Based on End User, the market is segmented into Blood component providers & blood centers, Academic & research institutes, Pharmaceutical & biotechnology companies, Hospitals & transfusion centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Leukapheresis Market

The global leukapheresis market is primarily driven by the growing prevalence of hematologic disorders, including leukemia and lymphoma. As the incidence of these conditions continues to rise, the demand for effective treatment options becomes increasingly critical. Leukapheresis is instrumental in managing elevated white blood cell counts associated with these disorders, as it facilitates the rapid removal of leukemic cells from the bloodstream. This procedure not only alleviates symptoms but also helps in preparing patients for further therapeutic interventions. Consequently, the increasing recognition of leukapheresis as a vital treatment option significantly fuels market growth in this sector.

Restraints in the Global Leukapheresis Market

The global leukapheresis market faces several challenges that may impede its growth. A significant factor is the limited awareness of both healthcare providers and patients regarding the advantages of leukapheresis procedures. This lack of knowledge highlights the need for comprehensive educational initiatives aimed at fostering a better understanding of this therapeutic option. Additionally, the high expenses associated with leukapheresis devices and consumables pose another barrier, especially in resource-limited environments. Moreover, the requirement for skilled healthcare professionals to conduct these procedures further complicates accessibility, underscoring the necessity for targeted strategies to improve awareness and affordability in the market.

Market Trends of the Global Leukapheresis Market

The global leukapheresis market is witnessing a significant trend towards integration with cell-based therapies, particularly chimeric antigen receptor (CAR) T-cell therapy. This approach allows for the efficient collection and genetic modification of patient-derived white blood cells, which are essential for developing effective treatments against cancer. As healthcare providers increasingly recognize the potential of combining leukapheresis with advanced cell therapies, demand for leukapheresis technologies is expected to surge. This synergy not only enhances treatment efficacy but also drives innovation in leukapheresis procedures, positioning it as a cornerstone in the evolving landscape of personalized cancer care.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Leukapheresis Market Size by Type & CAGR (2024-2031)

Global Leukapheresis Market Size by Application & CAGR (2024-2031)

Global Leukapheresis Market Size by End User & CAGR (2024-2031)

Global Leukapheresis Market Size & CAGR (2024-2031)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendation

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기